Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03284203 · ClinicalTrials.gov registry record · NA
Feasibility of At-Home Handheld Spirometry
A NA study, sponsored by University of Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03284203 is a NA study that was terminated before completion, run by University of Chicago. The registered enrollment target is 8 participants.
The verdict
NCT03284203, a NA study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The investigators' central hypotheses predict that the handheld spirometry device will be feasible for inpatient and at-home use, and is equally efficacious at determining lung function when compared to traditional, bedside spirometry measurements. To test these hypotheses, the investigators propose the following specific aims: Specific Aim 1: Determine the correlation of SpiroPD handheld spirometry measurements with bedside Koko spirometry lung function. Hypothesis: Correlation between the two lung function tests will be substantial for both hospitalized and ambulatory patients. Specific Aim 2: To determine the feasibility, adherence, and preliminary management efficacy of home SpiroPD testing. Hypotheses: (1) Patients will demonstrate substantial adherence to daily home spirometry testing; (2) medication adherence will increase significantly in patients who are adherent to daily home spirometry testing; (3) acute care utilization will decrease significant in adherent patients.
Interventions
- DEVICE SpiroPD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2017-09-30 |
| Est. Completion | 2018-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03284203
The ClinicalTrials.gov registry entry for NCT03284203 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SpiroPD is the first listed.
NCT03284203 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03284203 about?
NCT03284203 is a clinical study titled "Feasibility of At-Home Handheld Spirometry". The investigators' central hypotheses predict that the handheld spirometry device will be feasible for inpatient and at-home use, and is equally efficacious at determining lung function when compared to traditional, bedside spirometry measurements. To test these hypotheses, the investigators propose...
What is the current status of trial NCT03284203?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2017-09-30. Estimated completion is 2018-03-01.
What interventions are being tested in trial NCT03284203?
The interventions under investigation include: SpiroPD (DEVICE).
Who is sponsoring clinical trial NCT03284203?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.